产品
编 号：F309722
分子式：C18H19BrN2S
分子量：375.33
分子式：C18H19BrN2S
分子量：375.33
产品类型
规格
价格
是否有货
10mM*1mL in DMSO
询价
询价
5mg
440
In-stock
10mg
660
In-stock
25mg
1191
In-stock
50mg
1980
In-stock
100mg
3120
In-stock
结构图
CAS No: 298197-04-3
产品详情
生物活性：
Fatostatin hydrobromide (125B11 hydrobromide), a specific inhibitor of SREBP activation, impairs the activation of SREBP-1 and SREBP-2. Fatostatin hydrobromide binds to SCAP (SREBP cleavage-activating protein), and inhibits the ER-Golgi translocation of SREBPs. Fatostatin hydrobromide decreases the transcription of lipogenic genes in cells. Fatostatin hydrobromide possesses antitumor properties, and lowers hyperglycemia in ob/ob mice.
体内研究：
Fatostatin hydrobromide (30 mg/kg; 150 mL; i.p.; daily for 28 days)通过减少甘油三酯 (TG) 储存来减少肥胖、改善脂肪肝，并降低 ob/ob 小鼠中的高血糖。Animal Model:Four-to-five-week-old homozygous male obese (ob/ob) mice (C57BL/6J)
Dosage:30 mg/kg; 150 mL
Administration:i.p. injection; daily for 28 days
Result:Blocked increases in body weight, blood glucose, and hepatic fat accumulation in obese ob/ob mice, even under uncontrolled food intake.
体外研究：
Fatostatin hydrobromide (0.1-1 μM；3 d) 抑制雄激素非依赖性前列腺癌细胞增殖 (IC50=0.1 μM)，独立于已知的 IGF1 信号通路。Fatostatin hydrobromide 抑制胰岛素诱导的 3T3-L1 细胞脂肪生成。
Fatostatin hydrobromide (125B11 hydrobromide), a specific inhibitor of SREBP activation, impairs the activation of SREBP-1 and SREBP-2. Fatostatin hydrobromide binds to SCAP (SREBP cleavage-activating protein), and inhibits the ER-Golgi translocation of SREBPs. Fatostatin hydrobromide decreases the transcription of lipogenic genes in cells. Fatostatin hydrobromide possesses antitumor properties, and lowers hyperglycemia in ob/ob mice.
体内研究：
Fatostatin hydrobromide (30 mg/kg; 150 mL; i.p.; daily for 28 days)通过减少甘油三酯 (TG) 储存来减少肥胖、改善脂肪肝，并降低 ob/ob 小鼠中的高血糖。Animal Model:Four-to-five-week-old homozygous male obese (ob/ob) mice (C57BL/6J)
Dosage:30 mg/kg; 150 mL
Administration:i.p. injection; daily for 28 days
Result:Blocked increases in body weight, blood glucose, and hepatic fat accumulation in obese ob/ob mice, even under uncontrolled food intake.
体外研究：
Fatostatin hydrobromide (0.1-1 μM；3 d) 抑制雄激素非依赖性前列腺癌细胞增殖 (IC50=0.1 μM)，独立于已知的 IGF1 信号通路。Fatostatin hydrobromide 抑制胰岛素诱导的 3T3-L1 细胞脂肪生成。
产品资料
Copyright©2015-2024 沪ICP备2022026524号-1
沪公网安备